Radiopharm Theranostics Limited
USD4.17
+0.04 (+0.97%)
CEO
Riccardo Canevari
IPO Date
2024-12-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
AU
Open
$4.13
Prev. Close
$4.13
Day Low
$4.00
Day High
$4.30
52W Low
$3.62
52W High
$16.25
Market Cap
$0.01B
Volume
0.03M
| -0.3 |
| 30 Jun 2023 | FY | -1027.6% | -11838.6% | -78.0% | -46.2% | 0.00 | 1.23 | -0.9 |
| 30 Jun 2022 | FY | -33661.6% | -343550.9% | -48.2% | -36.4% | 0.00 | 3.46 | -1.2 |
| 30 Jun 2021 | FY | 0.0% | 0.0% | 389.1% | -1451.0% | -0.47 | 0.21 | -204.0 |
| -0.7 |
| 31 Dec 2024 | Q2 | -523.9% | -768.3% | -35.2% | -20.3% | 0.00 | 3.37 | -0.1 |
| 30 Jun 2024 | Q4 | -7275.8% | -7750.2% | -82.5% | -32.2% | 0.00 | 1.30 | -0.1 |
| 31 Dec 2023 | Q2 | -38.6% | -609.0% | -102.2% | -39.1% | 0.00 | 0.50 | -0.3 |
| 30 Jun 2023 | Q4 | -387.2% | -2264.8% | -35.0% | -26.5% | 0.00 | 3.46 | -0.4 |
| 31 Dec 2022 | Q2 | -1482.0% | -4293.4% | -20.3% | -14.8% | 0.00 | 2.05 | -0.5 |
| 30 Jun 2022 | Q4 | 13483816.7% | 108576700.0% | -20.7% | -15.6% | 0.00 | 3.46 | -0.7 |
| 31 Dec 2021 | Q2 | -11361883.3% | -144923366.7% | -23.7% | -19.1% | 0.00 | 5.34 | -1.4 |
| 30 Jun 2021 | Q4 | 0.0% | 0.0% | 194.5% | -725.5% | -0.47 | 0.21 | -102.0 |